O1. Obtaining and structural characterization of the components (collagen and pyrrole-sulfonamide hybrids) needed for proposed formulas.

O2. In vitro evaluation of the cyto/hemocompatibility, antimicrobial, antibiofilm, antioxidant, immunomodulatory and pro-wound healing effects for both individual constituents and designed collagen-based formulas.

O3. The optimization and verification of compositional consistency for the formulas exhibiting the most promising biological activity.

O4. Project management and dissemination.